Skip to main navigation Skip to search Skip to main content

Aberrant Cell Signalling In Breast Cancer

  • Wakelam, Mike (Principal Investigator)

Project Details

Short titleAberrant Cell Signalling In Breast Cancer
StatusFinished
Effective start/end date1/10/96 → 31/12/99

Funding

  • GlaxoSmithKline (United Kingdom)